STOCK TITAN

Xos, Inc. (XOSWW) SEC Filings

XOSWW NASDAQ

Welcome to our dedicated page for Xos SEC filings (Ticker: XOSWW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Xos's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Xos's regulatory disclosures and financial reporting.

Rhea-AI Summary

Xos, Inc. director and Chief Operating Officer Giordano Sordoni reported a tax-related share disposition tied to vested equity awards. The company withheld 9,636 shares of common stock at $3.66 per share to cover tax obligations from vesting Restricted Stock Unit (RSU) awards, rather than an open-market sale. After this withholding, Sordoni directly owns 1,626,407 shares of Xos common stock, which includes 465,944 unvested RSUs that may convert into additional shares as they vest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. Chief Financial Officer Liana Pogosyan had 3,164 shares of common stock withheld by the company at $3.66 per share to satisfy tax obligations tied to vesting of previously reported Restricted Stock Unit (RSU) awards. This is a tax-withholding disposition, not an open-market sale. Following the withholding, she directly holds 160,588 shares of common stock, which include 106,938 unvested RSUs that may convert into an equal number of shares as they vest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. director Dietmar Ostermann reported an open-market sale of 3,351 shares of Common Stock on 2026-06-08 at a weighted average price of $4.4512 per share. Footnotes state the shares were sold at prices ranging from $4.1785 to $5.1205. After this transaction, he directly holds 79,593 shares, which includes 62,377 unvested RSUs, so the sale represents only a portion of his overall stake.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Xos, Inc. director Stuart N. Bernstein reported an open-market sale of 4,000 shares of common stock on June 4, 2026 at a weighted average price of $5.2563 per share, with trade prices ranging from $5.07 to $5.4425.

Following the sale, he holds 84,058 shares of Xos common stock directly, which include 62,377 unvested RSUs. He also reports 4,133 shares held indirectly through Bernstein Investment Partners LLC, where he is the managing member.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. is registering up to $100,000,000 of securities on a shelf basis. This shelf prospectus permits the company to offer, from time to time, Common Stock, Preferred Stock, Debt Securities, Warrants and Units in any combination, up to an aggregate amount of $100,000,000, with specific terms to be provided in prospectus supplements.

As context, the filing states that as of June 5, 2026

8,037,156 shares of Common Stock were held by non-affiliates, representing an aggregate market value of $59,957,184 based on a reported sale price of $7.46 per share on June 3, 2026working capital and general corporate purposes, and distribution methods to be set forth in supplements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
-
Rhea-AI Summary

Xos, Inc. entered into securities purchase and placement agency agreements for a registered direct offering of 1,090,910 shares of common stock at $5.50 per share. The company closed the transaction shortly after signing.

The offering generated approximately $6.0 million in gross proceeds before fees and expenses. Roth Capital Partners, LLC acted as exclusive placement agent and will receive a 6.5% cash fee on gross proceeds plus reimbursement of up to $75,000 of expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Xos, Inc. files a prospectus supplement updating its at-the-market sales capacity under a Sales Agreement with Roth Capital Partners to up to $8,618,796 of common stock. The supplement cites a public float of $59,957,184 based on 8,037,156 shares outstanding as of June 5, 2026 and a prior 12-month issuance of $11,366,932 under the same Form S-3 instruction. The Sales Agreement pays Roth Capital Partners a 3.0% fee on aggregate gross proceeds. The prospectus supplement modifies the ATM Prospectus Supplement and Base Prospectus and is qualified by them.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Emerald Green Trust, previously a 10% owner of Xos, Inc., reported open-market sales totaling 400,000 shares of common stock on June 3–4, 2026 at weighted-average prices in the mid-$5 to mid-$6 range, pursuant to a Rule 10b5-1 trading plan established on November 21, 2025.

After these transactions, Emerald Green Trust directly holds 1,161,229 shares of Xos common stock, and the disclosure states that following the June 4, 2026 trades it ceased to be a beneficial owner of 10% or more of the outstanding common stock and is no longer subject to Section 16 reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Xos, Inc. is offering 1,090,910 shares of its common stock at an offering price of $5.50 per share pursuant to this prospectus supplement. The offering's aggregate public offering price is $6,000,005 with placement agent fees of $390,000 (6.5%). After placement agent fees and estimated offering expenses, estimated net proceeds to Xos are approximately $5.4 million. The prospectus states the offering will be conducted on a reasonable "best efforts" basis through Roth Capital Partners, LLC as exclusive placement agent and notes Nasdaq listing under the symbol XOS. Shares outstanding were 12,567,531 as of June 3, 2026 and are projected to be 13,658,441 after this Offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Xos, Inc. Chief Executive Officer and director Dakota Semler reported a bona fide gift of 30,000 shares of Common Stock. The transfer was a gift to several persons who are not immediate family members and did not involve a sale or purchase in the market.

After the gift, Semler holds 847,061 shares of Xos common stock directly, which include 499,430 unvested restricted stock units (RSUs). This filing mainly updates Semler’s reported ownership and reflects a non-cash, non-market disposition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Xos (XOSWW) SEC filings are available on StockTitan?

StockTitan tracks 91 SEC filings for Xos (XOSWW), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Xos (XOSWW)?

The most recent SEC filing for Xos (XOSWW) was filed on June 12, 2026.